Endometrial cancer is the most frequent gynecological malignancy, and, although
epidemiologically it mainly affects advanced age women, it can also affect young patients …

Endometrial cancer (EC) is a deleterious condition which strongly affects a woman's quality
of life. Although aggressive interventions should be considered to treat high-grade EC, a …

Objective To assess the efficacy of metformin in megestrol acetate (MA)‐based fertility‐
sparing treatment for patients with atypical endometrial hyperplasia (AEH) and endometrioid …

Objective Deficient expression of mismatch repair proteins (MMR) has been suggested to be
a predictor of resistance of atypical endometrial hyperplasia (AEH) and early endometrial …

Objective This study aimed to evaluate the efficacy of comprehensive hysteroscopic
evaluation and lesion resection combined with progestin therapy in young patients with …

One emerging problem for onco-gynecologists is the incidence of premenopausal patients
under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to …

Objective The present study investigated long-term outcomes of medroxyprogesterone
acetate (MPA) plus metformin therapy in terms of control of atypical endometrial hyperplasia …

Objective: The conservative treatment of endometrial hyperplasia without atypia (HWA),
atypical endometrial hyperplasia (AH/EIN) and early endometrioid carcinoma (EEC) is …

Almost all standard therapies for gynecologic cancer, including surgical intervention,
gonadotoxic chemotherapy, and radiation therapy, threaten a woman's childbearing …

Objective To investigate the adjuvant efficacy of metformin treatment to achieve pathological
complete response (CR) in patients with endometrial complex hyperplasia (CH) and …